Product Information
BINOSTO 70 MG EFFERVESCENT TAB is a brand product labeled by Radius Health, Inc., priced at $71.2260 per EA under NDC 70539040004. Its NADAC has been published 68 times since Jun 18, 2025.
FDA first approved this application on Mar 12, 2012.
The High Outlier badge above means this manufacturer's average price in the alendronate sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
91.37 mg/1
Manufacturer
Radius Health, Inc.NDC
70539040004
Classification
Brand
Dosage Form
TABLET, EFFERVESCENT
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ALENDRONATE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA202344FDA Approved
3/12/2012
On Market Since
3/12/2012
Pharmacological Classes
Price Statistics
The NADAC for BINOSTO 70 MG EFFERVESCENT TAB has been published 68 times since Jun 18, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $71.2260 per EA |
|---|---|
| All-time high | $71.8530 (May 13, 2026) |
| All-time low | $71.2260 (Sep 23, 2026) |
| 52-week high | $71.8530 |
| 52-week low | $71.2260 |
| Median price | $71.8530 |
| Average price | $71.7778 |
| Largest weekly change | -0.6% (Sep 23, 2026) |
| Weeks tracked | 68 |
| Tracking since | Jun 18, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the alendronate sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Radius Health, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
alendronate sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bisphosphonate class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BINOSTO 70 MG EFFERVESCENT TAB?
The current National Average Drug Acquisition Cost (NADAC) for BINOSTO 70 MG EFFERVESCENT TAB, manufactured by Radius Health, Inc., is $71.2260 per EA (NDC 70539040004), effective Sep 30, 2026.
How has the price of BINOSTO 70 MG EFFERVESCENT TAB changed over time?
Over the history we have for it, the NADAC for BINOSTO 70 MG EFFERVESCENT TAB has held within roughly two percent of its current level. It has been tracked across 68 weekly CMS publications since Jun 18, 2025.
What are the highest and lowest recorded NADAC prices for BINOSTO 70 MG EFFERVESCENT TAB?
Since Jun 18, 2025, the NADAC for BINOSTO 70 MG EFFERVESCENT TAB has ranged from a low of $71.2260 (Sep 23, 2026) to a high of $71.8530 (May 13, 2026), with a median of $71.8530 per EA.
Are there cheaper alternatives to BINOSTO 70 MG EFFERVESCENT TAB?
No other NADAC-published product currently shares the active ingredient and strength of BINOSTO 70 MG EFFERVESCENT TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BINOSTO 70 MG EFFERVESCENT TAB?
BINOSTO 70 MG EFFERVESCENT TAB (NDC 70539040004) is labeled by Radius Health, Inc., and CMS classifies it as a brand product.